Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dalia Elganainy, M.D.

Concepts (71)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cholangiocarcinoma220205770.520 Why?
Bile Duct Neoplasms220206240.520 Why?
Carcinoma, Pancreatic Ductal6202317620.480 Why?
Pancreatic Neoplasms5202354540.260 Why?
Image Processing, Computer-Assisted4202089250.170 Why?
Digestive System Neoplasms12019820.160 Why?
Pancreatic Ducts120183310.130 Why?
Nanostructures120205490.120 Why?
Models, Theoretical3202135600.110 Why?
Antimetabolites, Antineoplastic120176460.110 Why?
Antineoplastic Agents, Phytogenic120176150.110 Why?
Adenocarcinoma2202263610.110 Why?
Tomography, X-Ray Computed42020206990.100 Why?
Drug Carriers120177010.100 Why?
Deoxycytidine120178860.100 Why?
Tumor Burden3202118890.080 Why?
Immunotherapy2202147460.070 Why?
Survival Analysis12018100890.060 Why?
Nanoparticles1201719650.060 Why?
Multivariate Analysis12018120610.060 Why?
Antibodies, Monoclonal1202092370.050 Why?
Neoplasms32021223360.050 Why?
Claudins120231180.050 Why?
Drug Resistance, Neoplasm1201753340.050 Why?
Antineoplastic Combined Chemotherapy Protocols22022118590.050 Why?
Xenograft Model Antitumor Assays2202036050.040 Why?
Calibration120228130.040 Why?
Neoadjuvant Therapy2202228970.040 Why?
Treatment Outcome32021652030.040 Why?
Cell Line, Tumor32020170710.040 Why?
Area Under Curve1202116380.030 Why?
Drug Compounding120172360.030 Why?
Aged, 80 and over22018594970.030 Why?
Caveolin 1120172550.030 Why?
Humans1220237660190.030 Why?
Neoplasm Staging22018112020.030 Why?
Pancreatectomy120188250.030 Why?
RNA1202327150.030 Why?
ROC Curve1202136140.030 Why?
Middle Aged420202230350.020 Why?
Aged320201711700.020 Why?
Phantoms, Imaging1201924740.020 Why?
Mice, Nude1201736100.020 Why?
Immunologic Factors1202015920.020 Why?
Linear Models1202158720.020 Why?
Male520203638800.020 Why?
DNA Mutational Analysis1201841120.020 Why?
Adult320202231100.020 Why?
Tumor Microenvironment1202239420.020 Why?
Algorithms22019140650.020 Why?
Up-Regulation1201741330.020 Why?
Neoplasm Metastasis1201848860.020 Why?
Gene Expression Regulation, Neoplastic1202386130.020 Why?
Feasibility Studies1201853010.020 Why?
Biopsy1201867680.020 Why?
Combined Modality Therapy1201885240.020 Why?
Models, Statistical1202150880.020 Why?
Female320203961740.020 Why?
Databases, Factual1202180620.020 Why?
Phenotype12023167140.010 Why?
Immunohistochemistry12018110350.010 Why?
Longitudinal Studies12020147470.010 Why?
Prognosis12023299050.010 Why?
Cell Proliferation12017104310.010 Why?
Apoptosis1201795070.010 Why?
Retrospective Studies22020815440.010 Why?
Prospective Studies12022548040.010 Why?
Animals220201688010.010 Why?
Follow-Up Studies12018392330.010 Why?
Time Factors12017401000.010 Why?
Mice12020818380.010 Why?
Elganainy's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (17)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.